ChemDiv and Avineuro Extend Collaboration on Alzheimer's Disease and Schizophrenia
26-Nov-2008 -
ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of their research and development collaboration including formulation, safety and early clinical development studies in areas of neurodegenerative and psychiatric disorders. R&D services will be provided by Chemical Diversity ...
Alzheimer's disease
psychiatric disorders
schizophrenia
+1